TherapeuticsMD Inc Reaches New 12-Month High at $6.15 (TXMD)
TherapeuticsMD (NASDAQ:TXMD)’s share price reached a new 52-week high on Tuesday, Analyst Ratings Net reports. The company traded as high as $6.15 and last traded at $5.94, with a volume of 1,175,929 shares traded. The stock had previously closed at $5.66.
A number of research firms have recently commented on TXMD. Analysts at Noble Financial reiterated a “buy” rating on shares of TherapeuticsMD in a research note to investors on Tuesday. They now have a $9.00 price target on the stock, up previously from $7.25. Finally, analysts at Cowen and Company initiated coverage on shares of TherapeuticsMD in a research note to investors on Wednesday, January 8th. They set an “outperform” rating on the stock.
In other TherapeuticsMD news, CEO Robert G. Finizio sold 50,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $5.70, for a total transaction of $285,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
TherapeuticsMD has a 1-year low of $1.65 and a 1-year high of $6.10. The stock has a 50-day moving average of $5.16 and a 200-day moving average of $3.70. The company’s market cap is $861.1 million.
TherapeuticsMD, Inc promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc (NASDAQ:TXMD) relative to its digital media network.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.